Sg Americas Securities, LLC G1 Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

$24.4 Billion
Q4 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$2.2 - $4.98 $73,893 - $167,268	33,588 Added 248.14%	47,124 $107,000
Q1 2024 May 06, 2024	BUY	$2.1 - $4.83 $28,425 - $65,378	13,536 New	13,536 $58,000
Q3 2023 Oct 13, 2023	BUY	$1.22 - $2.67 $211 - $461	173 Added 0.46%	37,726 $54,000
Q2 2023 Jul 10, 2023	SELL	$2.46 - $3.14 $4,086 - $5,215	-1,661 Reduced 4.24%	37,553 $94,000
Q1 2023 Apr 28, 2023	SELL	$2.57 - $8.16 $20,130 - $63,917	-7,833 Reduced 16.65%	39,214 $105,000
Q4 2022 Feb 02, 2023	BUY	$5.19 - $13.5 $45,069 - $117,234	8,684 Added 22.64%	47,047 $255,000
Q3 2022 Oct 31, 2022	BUY	$5.17 - $16.99 $1,070 - $3,516	207 Added 0.54%	38,363 $479,000
Q2 2022 Jul 29, 2022	BUY	$4.04 - $8.51 $573 - $1,208	142 Added 0.37%	38,156 $188,000
Q1 2022 Apr 29, 2022	SELL	$7.6 - $11.02 $65,778 - $95,378	-8,655 Reduced 18.55%	38,014 $289,000
Q4 2021 Feb 07, 2022	SELL	$10.16 - $16.17 $131,135 - $208,706	-12,907 Reduced 21.66%	46,669 $476,000
Q3 2021 Nov 01, 2021	BUY	$13.16 - $22.47 $253,053 - $432,075	19,229 Added 47.66%	59,576 $800,000
Q2 2021 Aug 12, 2021	SELL	$19.57 - $26.32 $96,812 - $130,205	-4,947 Reduced 10.92%	40,347 $885,000
Q1 2021 May 13, 2021	BUY	$17.58 - $32.59 $269,923 - $500,386	15,354 Added 51.28%	45,294 $1.09 Million
Q4 2020 Feb 04, 2021	SELL	$10.99 - $20.4 $333,249 - $618,589	-30,323 Reduced 50.32%	29,940 $539,000
Q3 2020 Nov 09, 2020	BUY	$11.55 - $23.75 $497,527 - $1.02 Million	43,076 Added 250.63%	60,263 $696,000
Q2 2020 Jul 20, 2020	SELL	$9.57 - $24.37 $43,122 - $109,811	-4,506 Reduced 20.77%	17,187 $417,000
Q1 2020 Apr 30, 2020	BUY	$9.07 - $26.32 $196,755 - $570,959	21,693 New	21,693 $239,000
Q3 2019 Nov 04, 2019	SELL	$22.78 - $40.58 $111,257 - $198,192	-4,884 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$16.03 - $31.1 $235,448 - $456,796	-14,688 Reduced 75.05%	4,884 $150,000
Q1 2019 Apr 29, 2019	SELL	$14.4 - $21.45 $447,307 - $666,301	-31,063 Reduced 61.35%	19,572 $325,000
Q4 2018 Feb 01, 2019	BUY	$16.51 - $51.33 $835,983 - $2.6 Million	50,635 New	50,635 $970,000
Q3 2018 Nov 06, 2018	SELL	$43.15 - $67.97 $421,057 - $663,251	-9,758 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$35.06 - $51.17 $342,115 - $499,316	9,758 New	9,758 $424,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account